MedPath

Validation of the Utility of Ophthalmology Intelligent Diagnostic System

Completed
Conditions
Ophthalmopathy
Artificial Intelligence
Interventions
Device: Ophthalmology diagnostic system.
Registration Number
NCT03499145
Lead Sponsor
Sun Yat-sen University
Brief Summary

The prevention and treatment of diseases via artificial intelligence represents an ultimate goal in computational medicine. Application scenarios of the current medical algorithms are too simple to be generally applied to real-world complex clinical settings. Here, the investigators use "deep learning" and "visionome technique", an novel annotation method for artificial intelligence in medical, to create an automatic detection and classification system for four key clinical scenarios: 1) mass screening, 2) comprehensive clinical triage, 3) hyperfine diagnostic assessment, and 4) multi-path treatment planning. The investigator also establish a telemedicine system and conduct clinical trial and website-based study to validate its versatility.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
615
Inclusion Criteria
  • Patients and residents who underwent ophthalmic examination of the eye and recorded their ocular information in the outpatient clinic and community.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Eligible patients for AI test.Ophthalmology diagnostic system.Device: ophthalmology diagnostic system. An artificial intelligence to make comprehensive evaluation and treatment decision of ocular diseases.
Primary Outcome Measures
NameTimeMethod
The proportion of accurate, mistaken and miss detection of the ophthalmology diagnostic system.Up to 5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath